Search results for PX-TA1010

Rituximab Biosimilar – Anti-MS4A1 mAb – Research Grade, ProteoGenix, PX-TA1010

Description of Rituximab Biosimilar - Anti-MS4A1 mAb - Research Grade General information about Rituximab Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein it triggers cell death. Rituximab is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers. This product is for research use only.